1. Home
  2. LCLN vs ZVRA Comparison

LCLN vs ZVRA Comparison

Compare LCLN & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln International Inc. Class A Common Stock

LCLN

Lincoln International Inc. Class A Common Stock

HOLD

Current Price

$23.67

Market Cap

821.7M

Sector

Finance

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$9.81

Market Cap

689.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCLN
ZVRA
Founded
1996
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
821.7M
689.4M
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
LCLN
ZVRA
Price
$23.67
$9.81
Analyst Decision
Buy
Strong Buy
Analyst Count
7
9
Target Price
★ $27.07
$25.00
AVG Volume (30 Days)
342.2K
★ 744.9K
Earning Date
11-05-2026
11-03-2026
Dividend Yield
★ 1.14%
N/A
EPS Growth
N/A
★ 159.21
EPS
N/A
★ 0.74
Revenue
N/A
★ $106,470,000.00
Revenue This Year
$28.20
$43.97
Revenue Next Year
$15.26
$15.93
P/E Ratio
★ N/A
$14.00
Revenue Growth
N/A
★ 350.91
52 Week Low
$20.05
$8.01
52 Week High
$27.55
$15.04

Technical Indicators

Market Signals
Indicator
LCLN
ZVRA
Relative Strength Index (RSI) 45.12 36.35
Support Level $22.81 $9.29
Resistance Level $23.75 $11.19
Average True Range (ATR) 0.87 0.46
MACD 0.02 -0.03
Stochastic Oscillator 24.10 3.61

Price Performance

Historical Comparison
LCLN
ZVRA

About LCLN Lincoln International Inc. Class A Common Stock

Lincoln International Inc is an independent investment banking advisory company focused on private capital markets. The company operates its business through its two operating segments: Investment Banking Advisory and Valuations and Opinions. The Investment Banking Advisory segment offers a range of services related to mergers and acquisitions, with key areas of focus including sell-side advisory, buy-side advisory, asset sales and divestitures, restructuring, primary and secondary capital raising, and merger-related engagements. The Valuations and Opinions segment provides valuation services to investment funds and financial institutions. The majority of revenue is derived from the Investment Banking Advisory segment. Geographically, the maximum revenue is derived from the Americas.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: